The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Robert W. Carlson; Benjamin O. Anderson; Harold J. Burstein; W. Bradford Carter; Stephen B. Edge; William B. Farrar; Lori J. Goldstein; William J. Gradishar; Daniel F. Hayes; Clifford A. Hudis; Mohammad Jahanzeb; Britt Marie Ljung; Krystyna Kiel; Lawrence B. Marks; Beryl McCormick; Lisle M. Nabell; Lori J. Pierce; Elizabeth C. Reed; Samuel M. Silver; Mary Lou Smith; George Somlo; Richard L. Theriault; John H. Ward; Eric P. Winer; Antonio C. Wolff

doi:10.6004/jnccn.2007.0025

The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Robert W. Carlson, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, William B. Farrar, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Mohammad Jahanzeb, Britt Marie Ljung, Krystyna Kiel, Lawrence B. Marks, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Elizabeth C. Reed, Samuel M. Silver, Mary Lou SmithGeorge Somlo, Richard L. Theriault, John H. Ward, Eric P. Winer, Antonio C. Wolff

School of Medicine

Research output: Contribution to journal › Review article › peer-review

54 Scopus citations

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

Original language	English (US)
Pages (from-to)	246-312
Number of pages	67
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	5
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2007.0025
State	Published - Mar 2007

Keywords

Adjuvant therapy
Breast cancer
Breast-conserving therapy
Chemotherapy
Ductal carcinoma in situ
Endocrine therapy
Lobular carcinoma in situ
Mastectomy
NCCN Clinical Practice Guidelines
Radiation
Therapy

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2007.0025

Cite this

Carlson, R. W., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., Hayes, D. F., Hudis, C. A., Jahanzeb, M., Ljung, B. M., Kiel, K., Marks, L. B., McCormick, B., Nabell, L. M., Pierce, L. J., Reed, E. C., Silver, S. M., ... Wolff, A. C. (2007). The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 5(3), 246-312. https://doi.org/10.6004/jnccn.2007.0025

Carlson, RW, Anderson, BO, Burstein, HJ, Carter, WB, Edge, SB, Farrar, WB, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, CA, Jahanzeb, M, Ljung, BM, Kiel, K, Marks, LB, McCormick, B, Nabell, LM, Pierce, LJ, Reed, EC, Silver, SM, Smith, ML, Somlo, G, Theriault, RL, Ward, JH, Winer, EP & Wolff, AC 2007, 'The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 3, pp. 246-312. https://doi.org/10.6004/jnccn.2007.0025

@article{f9e5e8074d784bf29fcd613bb8e12d92,

title = "The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology{\texttrademark}",

abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.",

keywords = "Adjuvant therapy, Breast cancer, Breast-conserving therapy, Chemotherapy, Ductal carcinoma in situ, Endocrine therapy, Lobular carcinoma in situ, Mastectomy, NCCN Clinical Practice Guidelines, Radiation, Therapy",

author = "Carlson, {Robert W.} and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Carter, {W. Bradford} and Edge, {Stephen B.} and Farrar, {William B.} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Hudis, {Clifford A.} and Mohammad Jahanzeb and Ljung, {Britt Marie} and Krystyna Kiel and Marks, {Lawrence B.} and Beryl McCormick and Nabell, {Lisle M.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Silver, {Samuel M.} and Smith, {Mary Lou} and George Somlo and Theriault, {Richard L.} and Ward, {John H.} and Winer, {Eric P.} and Wolff, {Antonio C.}",

year = "2007",

month = mar,

doi = "10.6004/jnccn.2007.0025",

language = "English (US)",

volume = "5",

pages = "246--312",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - The NCCN. Invasive breast cancer

T2 - Clinical practice guidelines in oncology™

AU - Carlson, Robert W.

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Carter, W. Bradford

AU - Edge, Stephen B.

AU - Farrar, William B.

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford A.

AU - Jahanzeb, Mohammad

AU - Ljung, Britt Marie

AU - Kiel, Krystyna

AU - Marks, Lawrence B.

AU - McCormick, Beryl

AU - Nabell, Lisle M.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Silver, Samuel M.

AU - Smith, Mary Lou

AU - Somlo, George

AU - Theriault, Richard L.

AU - Ward, John H.

AU - Winer, Eric P.

AU - Wolff, Antonio C.

PY - 2007/3

Y1 - 2007/3

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

KW - Adjuvant therapy

KW - Breast cancer

KW - Breast-conserving therapy

KW - Chemotherapy

KW - Ductal carcinoma in situ

KW - Endocrine therapy

KW - Lobular carcinoma in situ

KW - Mastectomy

KW - NCCN Clinical Practice Guidelines

KW - Radiation

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33947518806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947518806&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2007.0025

DO - 10.6004/jnccn.2007.0025

M3 - Review article

C2 - 17439758

AN - SCOPUS:33947518806

SN - 1540-1405

VL - 5

SP - 246

EP - 312

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 3

ER -

The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this